Stay updated on Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Locations section with Virginia and its details; removed the HHS Vulnerability Disclosure and Virginia Locations, and updated to Revision: v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:14:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' instead of 'No Results Posted', indicating that trial results have been submitted.
    Difference
    0.1%
    Check dated 2025-12-16T02:52:39.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.2.0 to v3.3.2 with no changes to study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:53:20.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A government funding status notice previously shown on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T15:03:09.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Study Completion (Estimated) is now listed as 2031-01, and the Study Record Dates show a new update (Last Update Posted 2025-03-27) with QC criteria updates.
    Difference
    0.5%
    Check dated 2025-11-03T01:27:00.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T10:25:07.000Z thumbnail image

Stay in the know with updates to Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.